Skip to main content

Table 1 Characteristics of study participants in a 2-year soy trial

From: Inflammatory markers in a 2-year soy intervention among premenopausal women

Variable Controls Intervention P-value2
  Mean [SD] Mean [SD]  
Number obf subjects 93 90  
Age at randomization (y) 42.7 [3.0] 43.3 [2.9] 0.21
Ethnicity1    
   Caucasian 35 [37.6%] 32 [35.6%] 0.96
   Japanese 24 [25.8%] 25 [27.8%]  
   Hawaiian 11 [11.8%] 12 [13.3%]  
   Filipino 7 [7.5%] 4 [4.4%]  
   Chinese 7 [7.5%] 7 [7.8%]  
   Mixed/other 9 [9.6%] 10 [11.3%]  
Body weight (kg)    
   At baseline 68.3 [17.5] 67.9 [15.2] 0.87
   After 2 y 69.1 [16.1] 69.1 [15.5] 0.99
   Change over 2 y 0.8 [4.1] 1.2 [3.6] 0.54
Body mass index (kg/m2)    
   At baseline 26.1 [6.1] 26.2 [5.4] 0.96
   After 2 y 26.4 [6.5] 26.6 [5.5] 0.85
   Change over 2 y 0.32 [1.5] 0.45 [1.4] 0.54
Lifetime soy intake (svgs) 2440 [2967] 2044 [2541] 0.33
Soy consumption (svgs/y)1    
   During early life >0 49 [52.7%] 47 [52.2%] 0.95
   During adult life >36 47 [50.5%] 45 [50.0%] 0.94
   Lifetime ≥ 27 49 [52.7%] 47 [52.2%] 0.95
Marker levels at baseline    
   CRP (mg/L) 2.31 [3.28] 1.95 [3.10] 0.44
   IL-6 (pg/mL) 1.36 [1.47] 1.06 [0.64] 0.08
   Adiponectin (μg/mL) 8.13 [3.68] 7.87 [4.13] 0.65
   Leptin (ng/mL) 19.06 [15.78] 19.45 [15.02] 0.87
  1. 1 Frequencies and percentages
  2. 2 p-values from χ2- and Student's t test